Pfizer Ends Studies on Drug for Treating Heart Disease
65762
The stunning announcement is likely to damage the companyÂs prospects for decades as research linked the drug to deaths and heart problems.
182166
An anti-arthritis drug used by 84 million patients worldwide, 400,000 of them in Britain, was withdrawn from the market yesterday after trials suggested it might nearly double the risk of heart attacks and strokes.
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
37828
A clinical trial of the blockbuster arthritis drug Celebrex was shut down yesterday after researchers found an increase in the risk of serious heart disease and strokes in those taking the
692172
German drug group Bayer said Monday that it had halted trials of its leading cancer treatment Nexavar for one of the main forms of lung cancer.
641075
German pharmaceuticals giant Bayer said it had decided to pull out of clinical testing of Repinotan, a compound used to treat stroke patients, because the drug had not lived up to expectations.
104130
A leading drug used by millions of people to lower blood pressure does not prevent deaths from heart attacks or other cardiovascular problems as well as other treatments, researchers said on Friday.
148326
NEW YORK - At the end of Pfizer&#39;s annual analyst meeting, Chief Executive Hank McKinnell dropped a bombshell. Older, over-the-counter pain medicines may not be safe for the heart, McKinnell said, because there
109692
Contrary to what the product promises to do, the latest Viagra campaign has gone limp. According to US media reports, the US-based Food and Drug Administration has ordered drug major Pfizer to stop running
313404
A leading drug used by millions of  people to lower blood pressure does not prevent deaths from  heart attacks or other cardiovascular problems as well as other  treatments, researchers said on Friday.
625109
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drug maker's sister drug, Celebrex, doubled risk of heart  attacks.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
683010
NEW YORK, Dec. 2 -- Pfizer Inc. announced Saturday that it has cut off all clinical trials and development work for a cholesterol drug that was supposed to be a star product because of an unexpected number of deaths and cardiovascular problems among patients who used it.
308611
Investors dumped shares of Pfizer Inc. today in response to the drug giant's weekend announcement that it has halted development of a potential blockbuster cholesterol treatment.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
688234
NEW YORK -- Drug maker Pfizer said yesterday it would immediately stop advertising its best-selling arthritis pain reliever Celebrex to consumers after a study showed high doses of it were associated with an increased heart attack risk.